Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Month of birth as a risk factor for multiple sclerosis: an update.
The role of complement in neurological and neuropsychiatric diseases.
Mystery Case: Balo concentric sclerosis.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.
Expression and regulation of human endogenous retrovirus W elements.
Smokers run increased risk of developing anti-natalizumab antibodies.
Anorexia heralding the onset of neuromyelitis optica.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
Care of patients with multiple sclerosis.
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Hatha Yoga and Executive Function: A Systematic Review.
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
Insights into TREM2 biology by network analysis of human brain gene expression data.
Comparison of MERGE and Axial T2-Weighted Fast Spin-Echo Sequences for Detection of Multiple Sclerosis Lesions in the Cervical Spinal Cord.
Confounding Psychosis in the Postpartum Period.
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
[Pharmacological treatment of spasticity in multiple sclerosis].

Pages